Evidence map›Paper›PMID 40278765›Full record

ArticleTropical medicine and infectious disease2025

Baseline Seroprevalence of Arboviruses in Liberia Using a Multiplex IgG Immunoassay.

Albert To, Varney M Kamara, Davidetta M Tekah, Mohammed A Jalloh, Salematu B Kamara, Teri Ann S Wong, Aquena H Ball, Ludwig I Mayerlen, Kyle M Ishikawa, Hyeong Jun Ahn and 8 more

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Beyond Borders-Tackling Neglected Tropical Viral Diseases.Tropical medicine and infectious disease · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Albert ToDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.ORCID 0000-0002-7118-9803
Varney M KamaraDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.
Davidetta M TekahDepartment of Biological Sciences, Medical Science, T.J.R Faulkner College of Science and Technology, University of Liberia, Fendall 1000, Liberia.
Mohammed A JallohDepartment of Biological Sciences, Medical Science, T.J.R Faulkner College of Science and Technology, University of Liberia, Fendall 1000, Liberia.
Salematu B KamaraDepartment of Biological Sciences, Medical Science, T.J.R Faulkner College of Science and Technology, University of Liberia, Fendall 1000, Liberia.
Teri Ann S WongDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.ORCID 0000-0002-7110-657X
Aquena H BallDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.
Ludwig I MayerlenDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.ORCID 0009-0002-4083-0802
Kyle M IshikawaDepartment of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.ORCID 0000-0002-4181-8648
Hyeong Jun AhnDepartment of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.ORCID 0000-0002-1510-1125
Bode ShobayoNational Public Health Institute of Liberia, Monrovia 1000, Liberia.ORCID 0000-0002-4864-0248
Julius TeahtonNational Public Health Institute of Liberia, Monrovia 1000, Liberia.
Brien K HaunDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.
Wei-Kung WangDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.
John M BeresteckyDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.ORCID 0009-0007-4917-991X
Vivek R NerurkarDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.ORCID 0000-0002-2044-2784
Peter S HumphreyDepartment of Biological Sciences, Medical Science, T.J.R Faulkner College of Science and Technology, University of Liberia, Fendall 1000, Liberia.
Axel T LehrerDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.

Funding

Regulatory Compliance Core - Galveston National Laboratory BSL4 OperationsUC7AI094660 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Thomas Gary Ksiazek · 2011 to 2026
$208.8M
The Role of gp120 on Cardiovascular Disease in People Living with HIVU54MD007601 · NIMHD · UNIVERSITY OF HAWAII AT MANOA · PI JoAnn Umilani Tsark · 2017 to 2026
$59.5M
Tracking and Evaluation CoreU54GM138062 · NIGMS · UNIVERSITY OF HAWAII AT MANOA · PI SHIKUMA, CECILIA M. · 2021 to 2025
$15.5M
NPGH LEADERs YR12: OBSSR (Greenberg, Ngwafong Mukere) & NIBIB (Lee)D43TW009345 · FIC · UNIVERSITY OF WASHINGTON · PI Dibyadyuti Datta, Chandy C. John · 2017 to 2026
$15.2M
Small Grants ProgramP30GM114737 · NIGMS · UNIVERSITY OF HAWAII AT MANOA · PI NERURKAR, VIVEK RAMCHANDRA · 2015 to 2022
$8.1M
Preclinical Development of a Thermostable Trivalent Filovirus VaccineR01AI132323 · NIAID · UNIVERSITY OF HAWAII AT MANOA · PI LEHRER, AXEL T · 2017 to 2021
$6.3M
Pacific Center for Emerging Infectious Diseases ResearchP20GM103516 · NIGMS · UNIVERSITY OF HAWAII AT MANOA · PI YANAGIHARA, RICHARD · 2012 to 2014
$6.1M
Transdisciplinary Health Disparities Research Training for Native Hawaiians and Pacific StudentsT37MD008636 · NIMHD · UNIVERSITY OF HAWAII AT MANOA · PI KAHOLOKULA, JOSEPH KEAWE'AIMOKU, SY, ANGELA U · 2014 to 2025
$2.7M
Defining a Protective Ebola Vaccine in Non-Human PrimatesR01AI119185 · NIAID · UNIVERSITY OF HAWAII AT MANOA · PI LEHRER, AXEL T · 2015 to 2018
$2.1M
Sustainable Research Training and Capacity Building in Liberia for Emerging Viral EpidemicsD71TW010434 · FIC · UNIVERSITY OF HAWAII AT MANOA · PI NERURKAR, VIVEK RAMCHANDRA, WEEKS, OPHELIA INEZ · 2017 to 2020
$72k
American Society for Tropical Medicine and Hygiene NACDC HHS U01-GH-002256CGH CDC HHS U01 GH002256FIC NIH HHS D43 TW009345FIC NIH HHS D71 TW010434NIAID NIH HHS R01 AI119185NIAID NIH HHS R01 AI132323NIAID NIH HHS UC7 AI094660NIGMS NIH HHS P20 GM103516NIGMS NIH HHS P30 GM114737NIGMS NIH HHS U54 GM138062NIH HHS 3D43TW009345-23A12NIH HHS 5R01AI132323-21A5NIH HHS 5T37MD008636-23A9NIH HHS 5U54GM138062-23A3NIH HHS 5U54MD007601-23A37NIMHD NIH HHS T37 MD008636NIMHD NIH HHS U54 MD007601
6 · The paper itself

Abstract

Insect-borne viruses may account for a significant proportion of non-malaria and non-bacterial febrile illnesses in Liberia. Although the presence of many arthropod vectors has been documented, the collective burden of arbovirus infections and baseline pre-existing immunity remains enigmatic. Our goal was to determine the seroprevalence of arbovirus exposure across the country using a resource-sparing, multiplex immunoassay to determine IgG responses to immunodominant antigens. 532 human serum samples, from healthy adults, collected from 10 counties across Liberia, were measured for IgG reactivity against antigens of eight common flavi-, alpha-, and orthobunya/nairoviruses suspected to be present in West Africa. Approximately 32.5% of our samples were reactive to alphavirus (CHIKV) E2, ~7% were reactive separately to West Nile (WNV) and Zika virus (ZIKV) NS1, while 4.3 and 3.2% were reactive to Rift Valley Fever virus (RVFV) N and Dengue virus-2 (DENV-2) NS1, respectively. Altogether, 21.6% of our samples were reactive to ≥1 flavivirus NS1s. Of the CHIKV E2 reactive samples, 8.5% were also reactive to at least one flavivirus NS1, and six samples were concurrently reactive to antigens of all three arbovirus groups, suggesting a high burden of multiple arbovirus infections for some participants. These insights suggest the presence of these four arbovirus families in Liberia with low and moderate rates of flavi- and alphavirus infections, respectively, in healthy adults. Further confirmational investigation, such as mosquito surveillance or other serological tests, is warranted and should be conducted before initiating additional flavivirus vaccination campaigns. The findings of these studies can help guide healthcare resource mobilization, vector control, and animal husbandry practices.

Indexed as

arboviruscross-reactivityIgGLiberiamicrosphere immunoassayserosurveillance

Identifiers

PMID40278765
PMCPMC12031126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.